| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in BIVI over the last quarter tilts toward buying: insiders added a net 23,280 shares worth roughly $49K.
BIVI sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 16.1K | $33.5K | - | |
| Other | 6.0K | $13.0K | - | |
| CFO | 3.4K | $7.5K | - | |
| Dir | 727 | $1.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | Berman Richard J87 | Director | Sell | 10,984 | $6.13 | $67,288.00 | -32.1% | -47.1% | -91.8% | |
| Mar 28, 2023 | Berman Richard J87 | Director | Sell | 10,984 | $8.52 | $93,581.07 | -24.3% | -44.5% | -93.8% | |
| Dec 7, 2021 | Kim Joanne Wendy | CFO | Buy | 2,000 | $5.40 | $10,798.00 | New | -43.5% | +14.8% | |
| Nov 3, 2020 | Gorlin Steve | Director | Buy | 2,430 | $7.95 | $19,318.50 | +5.7% | - | - | |
| Oct 30, 2020 | Gorlin Steve | Director | Buy | 2,570 | $7.97 | $20,482.90 | +6.4% | - | - | |
| Oct 21, 2020 | Gorlin Steve | Director | Buy | 5,000 | $9.19 | $45,950.00 | +14.2% | - | - | |
| Oct 15, 2020 | Gorlin Steve | Director | Buy | 15,100 | $10.10 | $152,517.00 | +302.0% | - | - | |
| Oct 9, 2020 | Gorlin Steve | Director | Buy | 282 | $9.61 | $2,710.02 | +1.4% | - | - | |
| Oct 7, 2020 | Gorlin Steve | Director | Buy | 4,718 | $9.42 | $44,443.56 | +31.5% | - | - | |
| Sep 22, 2020 | Gorlin Steve | Director | Buy | 15,000 | $10.00 | $150,000.00 | New | - | - |